{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:37:12Z","timestamp":1784029032499,"version":"3.55.0"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,11,30]]},"DOI":"10.18632\/oncotarget.2604","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:36:57Z","timestamp":1442360217000},"page":"11641-11652","source":"Crossref","is-referenced-by-count":18,"title":["Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma"],"prefix":"10.18632","volume":"5","author":[{"given":"Iza","family":"Denis","sequence":"first","affiliation":[{"name":"Inserm, UMR892, Nantes, F-44000, France"},{"name":"CNRS, UMR6299, Nantes, F-44000, France"},{"name":"Universit\u00e9 Nantes, Nantes, F-44000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Cellerin","sequence":"additional","affiliation":[{"name":"Inserm, UMR892, Nantes, F-44000, France"},{"name":"CNRS, UMR6299, Nantes, F-44000, France"},{"name":"Universit\u00e9 Nantes, Nantes, F-44000, France"},{"name":"Service d'Oncologie M\u00e9dicale Thoracique et Digestive, H\u00f4pital La\u00ebnnec, CHU de Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gregoire","sequence":"additional","affiliation":[{"name":"Inserm, UMR892, Nantes, F-44000, France"},{"name":"CNRS, UMR6299, Nantes, F-44000, France"},{"name":"Universit\u00e9 Nantes, Nantes, F-44000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blanquart","sequence":"additional","affiliation":[{"name":"Inserm, UMR892, Nantes, F-44000, France"},{"name":"CNRS, UMR6299, Nantes, F-44000, France"},{"name":"Universit\u00e9 Nantes, Nantes, F-44000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,10,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.lungcan.2011.04.014","article-title":"Chemotherapy and targeted therapies for unresectable malignant mesothelioma","volume":"73","author":"Hassan","year":"2011","journal-title":"Lung Cancer"},{"key":"2","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Marchand","year":"1960","journal-title":"Br J Ind Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"J Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"Giaccone","year":"2005","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"van Meerbeeck","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"6","article-title":"Malignant mesothelioma: New insights into a rare disease","author":"Zanui","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"7","first-page":"523","article-title":"Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research\/World Cancer Research Fund, American Institute for Cancer Research, 1997","volume":"15","author":"Glade","year":"1999","journal-title":"Nutrition"},{"key":"8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10408398209527361","article-title":"Glucosinolates and their breakdown products in food and food plants","volume":"18","author":"Mullin","year":"1983","journal-title":"Crit Rev Food Sci Nutr"},{"key":"9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1024\/0300-9831.72.1.26","article-title":"Glucosinolates: bioavailability and importance to health","volume":"72","author":"Johnson","year":"2002","journal-title":"Int J Vitam Nutr Res"},{"issue":"Suppl 2","key":"10","first-page":"73","article-title":"The cancer chemopreventive actions of phytochemicals derived from glucosinolates","volume":"47","author":"Eggleston","year":"2008","journal-title":"Eur J Nutr"},{"key":"11","first-page":"1976s","article-title":"Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms","volume":"54","author":"Talalay","year":"1994","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1389200023337496","article-title":"Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans","volume":"3","author":"Chung","year":"2002","journal-title":"Curr Drug Metab"},{"key":"13","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/carcin\/bgp157","article-title":"Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells","volume":"30","author":"Srivastava","year":"2009","journal-title":"Carcinogenesis"},{"key":"14","doi-asserted-by":"crossref","first-page":"30151","DOI":"10.1074\/jbc.M802529200","article-title":"Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells","volume":"283","author":"Singh","year":"2008","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcb.240590825","article-title":"Chemoprevention by isothiocyanates","volume":"22","author":"Hecht","year":"1995","journal-title":"J Cell Biochem Suppl"},{"key":"16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4757-3230-6_14","article-title":"Brassica vegetables and cancer prevention. Epidemiology and mechanisms","volume":"472","author":"Goldbohm","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(00)02631-3","article-title":"Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China","volume":"356","author":"Yu","year":"2000","journal-title":"Lancet"},{"key":"18","first-page":"1403","article-title":"A prospective study of cruciferous vegetables and prostate cancer","volume":"12","author":"Willett","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s11095-005-7097-z","article-title":"Pharmacokinetics of dietary phenethyl isothiocyanate in rats","volume":"22","author":"Morris","year":"2005","journal-title":"Pharm Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1358\/dnp.2005.18.7.939350","article-title":"Chemopreventive functions of isothiocyanates","volume":"18","author":"Kong","year":"2005","journal-title":"Drug News Perspect"},{"key":"21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","article-title":"Identification of novel markers for the diagnosis of malignant pleural mesothelioma","volume":"178","author":"Gregoire","year":"2011","journal-title":"Am J Pathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/156800911797264761","article-title":"Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds","volume":"11","author":"Gregoire","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425255.2013.843668","article-title":"Exploring the effects of isothiocyanates on chemotherapeutic drugs","volume":"10","author":"Tumiatti","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jat.1284","article-title":"Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver","volume":"28","author":"Santos","year":"2008","journal-title":"J Appl Toxicol"},{"key":"25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Dolan","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1055\/s-2008-1081307","article-title":"Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents","volume":"74","author":"Singh","year":"2008","journal-title":"Planta Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/978-1-61779-998-3_40","article-title":"Histone H2AX phosphorylation: a marker for DNA damage","volume":"920","author":"Almasan","year":"2012","journal-title":"Methods Mol Biol"},{"key":"28","first-page":"948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Yang","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0098-2997(01)00010-3","article-title":"Redox signaling in macrophages","volume":"22","author":"Torres","year":"2001","journal-title":"Mol Aspects Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-2952(00)00319-1","article-title":"Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro","volume":"60","author":"Thornalley","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1054\/bjoc.2000.1636","article-title":"Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK","volume":"84","author":"Thornalley","year":"2001","journal-title":"Br J Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/mnfr.200800253","article-title":"Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells","volume":"53","author":"Young","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s12272-001-2158-2","article-title":"Phenethyl isothiocyanate induced apoptosis via down regulation of Bcl-2\/XIAP and triggering of the mitochondrial pathway in MCF-7 cells","volume":"31","author":"Cho","year":"2008","journal-title":"Arch Pharm Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1582-4934.2009.00877.x","article-title":"Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36","volume":"14","author":"Wang","year":"2010","journal-title":"J Cell Mol Med"},{"key":"35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cbi.2008.12.014","article-title":"Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling","volume":"179","author":"Kong","year":"2009","journal-title":"Chem Biol Interact"},{"key":"36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bcp.2012.11.017","article-title":"beta-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype","volume":"85","author":"Xu","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"37","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/mnfr.201000560","article-title":"Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin","volume":"55","author":"Chung","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/tx100187f","article-title":"Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates","volume":"23","author":"Chung","year":"2010","journal-title":"Chem Res Toxicol"},{"key":"39","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1183\/09031936.00102308","article-title":"Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma","volume":"34","author":"Gaudino","year":"2009","journal-title":"Eur Respir J"},{"key":"40","doi-asserted-by":"crossref","first-page":"e45354","DOI":"10.1371\/journal.pone.0045354","article-title":"Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy","volume":"7","author":"Stahel","year":"2012","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JTO.0b013e318233d6a9","article-title":"Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival","volume":"7","author":"Santoni-Rugiu","year":"2012","journal-title":"J Thorac Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1874467211205010088","article-title":"Base excision repair, the redox environment and therapeutic implications","volume":"5","author":"Martin","year":"2012","journal-title":"Curr Mol Pharmacol"},{"key":"43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1165\/ajrcmb\/7.1.95","article-title":"Antioxidant defense mechanisms in cultured pleural mesothelial cells","volume":"7","author":"Crapo","year":"1992","journal-title":"Am J Respir Cell Mol Biol"},{"key":"44","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.fct.2012.04.014","article-title":"Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells","volume":"50","author":"Chung","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"45","first-page":"359","article-title":"The tumoral microenvironment: feeding resources, battle field and therapeutic target in cancer","volume":"30","author":"Sautes-Fridman","year":"2014","journal-title":"Med Sci (Paris)"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T04:38:07Z","timestamp":1718080687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,18]]},"references-count":45,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2014,11,30]]}},"alternative-id":["2604","25361002"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2604","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,18]]}}}